Dr. Beverly Johnson, MD
Rheumatology (Rheumatology Physician)
1400 Pelham Parkway South Jacobi Medical Center, Room 3n-06
Bronx, NY 10461
At a glance
- Medical school
- Warren Alpert Medical School of Brown University (2006)
- Years since graduation
- 20
- In the NPI registry since
- 2008
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Medical school: Warren Alpert Medical School of Brown University
- 2008Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Rheumatology Physician primary
NY license 247479 -
Internal Medicine Physician
NY license 247479
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Urban Health Plan Inc (157 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Gabapentin Other prescribers in Bronx, NY | 96 |
| Prednisone Other prescribers in Bronx, NY | 70 |
| Hydroxychloroquine Sulfate Other prescribers in Bronx, NY | 58 |
| Diclofenac Sodium Other prescribers in Bronx, NY | 54 |
| Alendronate Sodium Other prescribers in Bronx, NY | 46 |
| Methotrexate (methotrexate sodium) Other prescribers in Bronx, NY | 36 |
| Enbrel Sureclick (etanercept) Other prescribers in Bronx, NY | 22 |
| Benlysta (belimumab) | 22 |
| Cyclobenzaprine Hcl Other prescribers in Bronx, NY | 20 |
| Meloxicam Other prescribers in Bronx, NY | 18 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 7 companies reported 21 payments worth $18,191 in total to this clinician.
| E.r. Squibb & Sons, L.l.c. | $11,795 |
|---|---|
| Genentech USA, Inc. | $5,895 |
| UCB, Inc. | $150 |
| Novartis Pharmaceuticals Corporation | $132 |
| AbbVie Inc. | $129 |
| AstraZeneca Pharmaceuticals LP | $74.52 |
| Janssen Scientific Affairs, LLC | $15.56 |
| Consulting Fee | $17,110 |
|---|---|
| Food and Beverage | $735 |
| Travel and Lodging | $346 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| E.r. Squibb & Sons, L.l.c. Dec 8, 2025 | Consulting Fee | $5,346 |
| Genentech USA, Inc. Apr 26, 2025 | Consulting Fee Gazyva · BioOncology | $5,315 |
| E.r. Squibb & Sons, L.l.c. Oct 9, 2025 | Consulting Fee | $2,048 |
| E.r. Squibb & Sons, L.l.c. Dec 8, 2025 | Consulting Fee | $2,019 |
| E.r. Squibb & Sons, L.l.c. Nov 12, 2025 | Consulting Fee | $998 |
| E.r. Squibb & Sons, L.l.c. Nov 10, 2025 | Consulting Fee | $910 |
| E.r. Squibb & Sons, L.l.c. Nov 26, 2025 | Consulting Fee | $475 |
| Genentech USA, Inc. Apr 26, 2025 | Travel and Lodging Gazyva · BioOncology · travel to Rosemont, IL · in-kind | $227 |
| Genentech USA, Inc. Apr 26, 2025 | Travel and Lodging Gazyva · BioOncology · travel to Rosemont, IL | $119 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $12,275 in research payments for these studies, mostly to the institutions running them.
- Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus
AbbVie Inc. · Active, not recruiting · NCT05843643
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.